| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $844.0M | +8.5% |
| Cost of Revenue | $251.0M | +8.3% |
| Gross Profit | $593.0M | +8.6% |
| R&D Expense | $173.1M | -2.1% |
| SG&A Expense | $86.0M | +2.0% |
| Operating Income | $35.0M | +143.4% |
| Pre-tax Income | $41.5M | +127.7% |
| Income Tax | $15.9M | +3175.1% |
| Net Income | $25.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $334.7M | +56.7% |
| Short-term Investments | $187.0M | +10.3% |
| Current Assets | $786.1M | +23.9% |
| Total Assets | $1.65B | +9.7% |
| Current Liabilities | $630.2M | +10.6% |
| Total Liabilities | $1.63B | +0.7% |
| Stockholders' Equity | $17.7M | +115.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $171.7M | +64.6% |
| Capital Expenditures | $3.4M | -21.6% |
| Investing Cash Flow | -$46.5M | +74.0% |
| Financing Cash Flow | $5.6M | -93.0% |
| Free Cash Flow | $168.2M | +68.4% |
| +117.1% |
| EPS (Basic) | $0.41 | +116.7% |
| EPS (Diluted) | $0.40 | +116.3% |